GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Maz
|
ENSMUSG00000030678.6 | MYC-associated zinc finger protein (purine-binding transcription factor) |
Zfp281
|
ENSMUSG00000041483.8 | zinc finger protein 281 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Maz | mm10_v2_chr7_-_127026479_127026496 | 0.80 | 5.4e-09 | Click! |
Zfp281 | mm10_v2_chr1_+_136624901_136624949 | 0.29 | 8.4e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_142657466 | 33.87 |
ENSMUST00000097936.2
ENSMUST00000000033.5 |
Igf2
|
insulin-like growth factor 2 |
chr6_-_115762346 | 30.89 |
ENSMUST00000166254.1
ENSMUST00000170625.1 |
Tmem40
|
transmembrane protein 40 |
chr11_+_74619594 | 26.69 |
ENSMUST00000100866.2
|
E130309D14Rik
|
RIKEN cDNA E130309D14 gene |
chrX_-_136215443 | 22.07 |
ENSMUST00000113120.1
ENSMUST00000113118.1 ENSMUST00000058125.8 |
Bex1
|
brain expressed gene 1 |
chr6_+_134929089 | 21.36 |
ENSMUST00000183867.1
ENSMUST00000184991.1 ENSMUST00000183905.1 |
RP23-45G16.5
|
RP23-45G16.5 |
chr14_-_70635946 | 19.46 |
ENSMUST00000022695.9
|
Dmtn
|
dematin actin binding protein |
chr17_+_29135056 | 18.85 |
ENSMUST00000087942.4
|
Rab44
|
RAB44, member RAS oncogene family |
chr7_-_143460989 | 18.58 |
ENSMUST00000167912.1
ENSMUST00000037287.6 |
Cdkn1c
|
cyclin-dependent kinase inhibitor 1C (P57) |
chrX_-_135210672 | 18.54 |
ENSMUST00000033783.1
|
Tceal6
|
transcription elongation factor A (SII)-like 6 |
chr17_+_48299952 | 17.54 |
ENSMUST00000170941.1
|
Treml2
|
triggering receptor expressed on myeloid cells-like 2 |
chr17_-_26201328 | 17.50 |
ENSMUST00000025019.2
|
Arhgdig
|
Rho GDP dissociation inhibitor (GDI) gamma |
chr17_-_26201363 | 17.36 |
ENSMUST00000121959.1
|
Arhgdig
|
Rho GDP dissociation inhibitor (GDI) gamma |
chr9_+_111019284 | 17.07 |
ENSMUST00000035077.3
|
Ltf
|
lactotransferrin |
chr6_+_134929118 | 17.01 |
ENSMUST00000185152.1
ENSMUST00000184504.1 |
RP23-45G16.5
|
RP23-45G16.5 |
chr1_+_134182404 | 16.46 |
ENSMUST00000153856.1
ENSMUST00000082060.3 ENSMUST00000133701.1 ENSMUST00000132873.1 |
Chi3l1
|
chitinase 3-like 1 |
chr5_+_122100951 | 16.40 |
ENSMUST00000014080.6
ENSMUST00000111750.1 ENSMUST00000139213.1 ENSMUST00000111751.1 ENSMUST00000155612.1 |
Myl2
|
myosin, light polypeptide 2, regulatory, cardiac, slow |
chr2_+_118111876 | 16.11 |
ENSMUST00000039559.8
|
Thbs1
|
thrombospondin 1 |
chr9_-_44288535 | 15.95 |
ENSMUST00000161354.1
|
Abcg4
|
ATP-binding cassette, sub-family G (WHITE), member 4 |
chr4_+_115059507 | 15.65 |
ENSMUST00000162489.1
|
Tal1
|
T cell acute lymphocytic leukemia 1 |
chr11_+_95009852 | 15.30 |
ENSMUST00000055947.3
|
Samd14
|
sterile alpha motif domain containing 14 |
chr4_-_88033328 | 14.84 |
ENSMUST00000078090.5
|
Mllt3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 |
chrX_-_7967817 | 14.83 |
ENSMUST00000033502.7
|
Gata1
|
GATA binding protein 1 |
chr12_-_76709997 | 14.60 |
ENSMUST00000166101.1
|
Sptb
|
spectrin beta, erythrocytic |
chrX_-_136203637 | 14.60 |
ENSMUST00000151592.1
ENSMUST00000131510.1 ENSMUST00000066819.4 |
Tceal5
|
transcription elongation factor A (SII)-like 5 |
chr7_-_142656018 | 14.07 |
ENSMUST00000178921.1
|
Igf2
|
insulin-like growth factor 2 |
chr3_+_114030532 | 14.03 |
ENSMUST00000123619.1
ENSMUST00000092155.5 |
Col11a1
|
collagen, type XI, alpha 1 |
chr4_+_46039202 | 13.89 |
ENSMUST00000156200.1
|
Tmod1
|
tropomodulin 1 |
chr7_-_24760311 | 13.71 |
ENSMUST00000063956.5
|
Cd177
|
CD177 antigen |
chr11_+_87794206 | 13.48 |
ENSMUST00000121303.1
|
Mpo
|
myeloperoxidase |
chr7_-_142659482 | 13.44 |
ENSMUST00000121128.1
|
Igf2
|
insulin-like growth factor 2 |
chrX_+_8271642 | 13.37 |
ENSMUST00000115590.1
|
Slc38a5
|
solute carrier family 38, member 5 |
chr16_+_4594683 | 13.21 |
ENSMUST00000014447.6
|
Glis2
|
GLIS family zinc finger 2 |
chr7_-_142578093 | 13.05 |
ENSMUST00000149974.1
ENSMUST00000152754.1 |
H19
|
H19 fetal liver mRNA |
chr15_-_77755218 | 12.92 |
ENSMUST00000070911.2
|
Apol8
|
apolipoprotein L 8 |
chr14_-_60086832 | 12.61 |
ENSMUST00000080368.5
|
Atp8a2
|
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
chr4_-_134018829 | 12.58 |
ENSMUST00000051674.2
|
Lin28a
|
lin-28 homolog A (C. elegans) |
chr11_-_102088471 | 12.33 |
ENSMUST00000017458.4
|
Mpp2
|
membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2) |
chr11_+_24080664 | 12.12 |
ENSMUST00000118955.1
|
Bcl11a
|
B cell CLL/lymphoma 11A (zinc finger protein) |
chr15_-_73184840 | 11.79 |
ENSMUST00000044113.10
|
Ago2
|
argonaute RISC catalytic subunit 2 |
chr5_-_122050102 | 11.72 |
ENSMUST00000154139.1
|
Cux2
|
cut-like homeobox 2 |
chr8_+_57455898 | 11.63 |
ENSMUST00000034023.3
|
Scrg1
|
scrapie responsive gene 1 |
chr11_+_116531744 | 11.54 |
ENSMUST00000106387.2
ENSMUST00000100201.3 |
Sphk1
|
sphingosine kinase 1 |
chr17_+_28769307 | 11.49 |
ENSMUST00000004986.6
|
Mapk13
|
mitogen-activated protein kinase 13 |
chr5_+_137288273 | 11.23 |
ENSMUST00000024099.4
ENSMUST00000085934.3 |
Ache
|
acetylcholinesterase |
chr19_-_24555819 | 11.01 |
ENSMUST00000112673.2
ENSMUST00000025800.8 |
Pip5k1b
|
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
chr15_-_82224330 | 11.01 |
ENSMUST00000089161.2
ENSMUST00000109535.2 |
Tnfrsf13c
|
tumor necrosis factor receptor superfamily, member 13c |
chr8_+_22974844 | 10.88 |
ENSMUST00000110688.2
ENSMUST00000121802.2 |
Ank1
|
ankyrin 1, erythroid |
chr12_+_109544498 | 10.88 |
ENSMUST00000126289.1
|
Meg3
|
maternally expressed 3 |
chr18_+_54422286 | 10.68 |
ENSMUST00000181269.1
|
Redrum
|
Redrum, erythroid developmental long intergenic non-protein coding transcript |
chr7_+_142498832 | 10.68 |
ENSMUST00000078497.8
ENSMUST00000105953.3 ENSMUST00000179658.1 ENSMUST00000105954.3 ENSMUST00000105952.3 ENSMUST00000105955.1 ENSMUST00000074187.6 ENSMUST00000180152.1 ENSMUST00000105950.4 ENSMUST00000105957.3 ENSMUST00000169299.2 ENSMUST00000105958.3 ENSMUST00000105949.1 |
Tnnt3
|
troponin T3, skeletal, fast |
chrX_-_136068236 | 10.48 |
ENSMUST00000049130.7
|
Bex2
|
brain expressed X-linked 2 |
chr12_+_109452833 | 10.12 |
ENSMUST00000056110.8
|
Dlk1
|
delta-like 1 homolog (Drosophila) |
chr2_+_164940742 | 10.12 |
ENSMUST00000137626.1
|
Mmp9
|
matrix metallopeptidase 9 |
chr11_+_58918004 | 10.10 |
ENSMUST00000108818.3
ENSMUST00000020792.5 |
Btnl10
|
butyrophilin-like 10 |
chr7_+_117380937 | 10.08 |
ENSMUST00000032892.5
|
Xylt1
|
xylosyltransferase 1 |
chr7_+_96211656 | 10.05 |
ENSMUST00000107165.1
|
Tenm4
|
teneurin transmembrane protein 4 |
chrX_+_136270302 | 9.99 |
ENSMUST00000113112.1
|
Ngfrap1
|
nerve growth factor receptor (TNFRSF16) associated protein 1 |
chr11_+_4236411 | 9.97 |
ENSMUST00000075221.2
|
Osm
|
oncostatin M |
chr2_-_91931675 | 9.88 |
ENSMUST00000111309.1
|
Mdk
|
midkine |
chr11_+_96931387 | 9.85 |
ENSMUST00000107633.1
|
Prr15l
|
proline rich 15-like |
chr11_+_95010277 | 9.82 |
ENSMUST00000124735.1
|
Samd14
|
sterile alpha motif domain containing 14 |
chrX_-_73659724 | 9.76 |
ENSMUST00000114473.1
ENSMUST00000002087.7 |
Pnck
|
pregnancy upregulated non-ubiquitously expressed CaM kinase |
chr5_-_122049822 | 9.75 |
ENSMUST00000111752.3
|
Cux2
|
cut-like homeobox 2 |
chr12_+_109545390 | 9.75 |
ENSMUST00000146701.1
|
Meg3
|
maternally expressed 3 |
chr7_+_143005046 | 9.64 |
ENSMUST00000009396.6
|
Tspan32
|
tetraspanin 32 |
chr2_+_131186942 | 9.61 |
ENSMUST00000028804.8
ENSMUST00000079857.8 |
Cdc25b
|
cell division cycle 25B |
chr11_+_87793470 | 9.57 |
ENSMUST00000020779.4
|
Mpo
|
myeloperoxidase |
chr15_+_80173642 | 9.53 |
ENSMUST00000044970.6
|
Mgat3
|
mannoside acetylglucosaminyltransferase 3 |
chr17_-_35066170 | 9.52 |
ENSMUST00000174190.1
ENSMUST00000097337.1 |
AU023871
|
expressed sequence AU023871 |
chr10_+_75564086 | 9.47 |
ENSMUST00000141062.1
ENSMUST00000152657.1 |
Ggt1
|
gamma-glutamyltransferase 1 |
chr2_-_28621932 | 9.42 |
ENSMUST00000028156.7
ENSMUST00000164290.1 |
Gfi1b
|
growth factor independent 1B |
chr13_-_51793650 | 9.41 |
ENSMUST00000110040.2
ENSMUST00000021900.7 |
Sema4d
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
chr17_+_43568096 | 9.40 |
ENSMUST00000167214.1
|
Pla2g7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) |
chr2_+_84734050 | 9.40 |
ENSMUST00000090729.2
|
Ypel4
|
yippee-like 4 (Drosophila) |
chrX_+_136270253 | 9.33 |
ENSMUST00000178632.1
ENSMUST00000053540.4 |
Ngfrap1
|
nerve growth factor receptor (TNFRSF16) associated protein 1 |
chr12_+_109549157 | 9.29 |
ENSMUST00000128458.1
ENSMUST00000150851.1 |
Meg3
|
maternally expressed 3 |
chr11_+_11684967 | 9.29 |
ENSMUST00000126058.1
ENSMUST00000141436.1 |
Ikzf1
|
IKAROS family zinc finger 1 |
chr4_+_115057410 | 9.25 |
ENSMUST00000136946.1
|
Tal1
|
T cell acute lymphocytic leukemia 1 |
chr11_-_102082464 | 9.20 |
ENSMUST00000100398.4
|
Mpp2
|
membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2) |
chr2_-_164779721 | 9.05 |
ENSMUST00000103095.4
|
Tnnc2
|
troponin C2, fast |
chr2_-_131562283 | 9.00 |
ENSMUST00000103184.3
|
Adra1d
|
adrenergic receptor, alpha 1d |
chr13_-_49248663 | 8.98 |
ENSMUST00000135784.1
ENSMUST00000021816.5 |
Susd3
|
sushi domain containing 3 |
chr7_-_142576492 | 8.96 |
ENSMUST00000140716.1
|
H19
|
H19 fetal liver mRNA |
chr11_+_117797660 | 8.95 |
ENSMUST00000106331.1
|
6030468B19Rik
|
RIKEN cDNA 6030468B19 gene |
chr1_-_182019927 | 8.84 |
ENSMUST00000078719.6
ENSMUST00000111030.3 ENSMUST00000177811.1 ENSMUST00000111024.3 ENSMUST00000111025.2 |
Enah
|
enabled homolog (Drosophila) |
chr6_+_141249161 | 8.84 |
ENSMUST00000043259.7
|
Pde3a
|
phosphodiesterase 3A, cGMP inhibited |
chr11_+_87793722 | 8.78 |
ENSMUST00000143021.2
|
Mpo
|
myeloperoxidase |
chr8_+_3665747 | 8.69 |
ENSMUST00000014118.2
|
1810033B17Rik
|
RIKEN cDNA 1810033B17 gene |
chr10_-_127341583 | 8.66 |
ENSMUST00000026474.3
|
Gli1
|
GLI-Kruppel family member GLI1 |
chr9_-_56635624 | 8.66 |
ENSMUST00000114256.1
|
Lingo1
|
leucine rich repeat and Ig domain containing 1 |
chr2_-_91931696 | 8.63 |
ENSMUST00000090602.5
|
Mdk
|
midkine |
chr5_+_76840597 | 8.62 |
ENSMUST00000120639.2
ENSMUST00000163347.1 ENSMUST00000121851.1 |
C530008M17Rik
|
RIKEN cDNA C530008M17 gene |
chr2_-_91931774 | 8.61 |
ENSMUST00000069423.6
|
Mdk
|
midkine |
chr5_-_134229581 | 8.59 |
ENSMUST00000111275.1
ENSMUST00000016094.6 ENSMUST00000144086.1 |
Ncf1
|
neutrophil cytosolic factor 1 |
chr7_-_135716374 | 8.56 |
ENSMUST00000033310.7
|
Mki67
|
antigen identified by monoclonal antibody Ki 67 |
chr2_+_173022360 | 8.56 |
ENSMUST00000173997.1
|
Rbm38
|
RNA binding motif protein 38 |
chr3_+_131110350 | 8.55 |
ENSMUST00000066849.6
ENSMUST00000106341.2 ENSMUST00000029611.7 |
Lef1
|
lymphoid enhancer binding factor 1 |
chr7_-_38107490 | 8.52 |
ENSMUST00000108023.3
|
Ccne1
|
cyclin E1 |
chr3_-_98859774 | 8.50 |
ENSMUST00000107016.3
ENSMUST00000149768.1 |
Hsd3b1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
chrX_-_111463149 | 8.46 |
ENSMUST00000096348.3
ENSMUST00000113428.2 |
Rps6ka6
|
ribosomal protein S6 kinase polypeptide 6 |
chr7_-_4752972 | 8.46 |
ENSMUST00000183971.1
ENSMUST00000182173.1 ENSMUST00000182738.1 ENSMUST00000184143.1 ENSMUST00000182111.1 ENSMUST00000182048.1 ENSMUST00000063324.7 |
Cox6b2
|
cytochrome c oxidase subunit VIb polypeptide 2 |
chr7_-_142578139 | 8.39 |
ENSMUST00000136359.1
|
H19
|
H19 fetal liver mRNA |
chr2_-_156839790 | 8.38 |
ENSMUST00000134838.1
ENSMUST00000137463.1 ENSMUST00000149275.2 |
Gm14230
|
predicted gene 14230 |
chr14_+_54640952 | 8.37 |
ENSMUST00000169818.2
|
Gm17606
|
predicted gene, 17606 |
chr4_+_11191726 | 8.35 |
ENSMUST00000029866.9
ENSMUST00000108324.3 |
Ccne2
|
cyclin E2 |
chr11_-_69617879 | 8.32 |
ENSMUST00000005334.2
|
Shbg
|
sex hormone binding globulin |
chr17_-_29237759 | 8.30 |
ENSMUST00000137727.1
ENSMUST00000024805.7 |
Cpne5
|
copine V |
chrX_+_8271381 | 8.29 |
ENSMUST00000033512.4
|
Slc38a5
|
solute carrier family 38, member 5 |
chr14_+_80000292 | 8.26 |
ENSMUST00000088735.3
|
Olfm4
|
olfactomedin 4 |
chr6_-_49214954 | 8.22 |
ENSMUST00000031838.7
|
Igf2bp3
|
insulin-like growth factor 2 mRNA binding protein 3 |
chr7_+_24462475 | 8.15 |
ENSMUST00000002284.9
|
Plaur
|
plasminogen activator, urokinase receptor |
chr11_-_118129219 | 8.15 |
ENSMUST00000106308.3
ENSMUST00000084803.5 |
Dnah17
|
dynein, axonemal, heavy chain 17 |
chr8_+_72761868 | 8.08 |
ENSMUST00000058099.8
|
F2rl3
|
coagulation factor II (thrombin) receptor-like 3 |
chr3_-_98859753 | 8.08 |
ENSMUST00000029465.6
|
Hsd3b1
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
chr7_+_110773658 | 7.98 |
ENSMUST00000143786.1
|
Ampd3
|
adenosine monophosphate deaminase 3 |
chr7_-_133123770 | 7.96 |
ENSMUST00000164896.1
ENSMUST00000171968.1 |
Ctbp2
|
C-terminal binding protein 2 |
chr4_+_134315112 | 7.95 |
ENSMUST00000105875.1
ENSMUST00000030638.6 |
Trim63
|
tripartite motif-containing 63 |
chr11_-_46312220 | 7.95 |
ENSMUST00000129474.1
ENSMUST00000093166.4 ENSMUST00000165599.2 |
Cyfip2
|
cytoplasmic FMR1 interacting protein 2 |
chr7_-_142666816 | 7.93 |
ENSMUST00000105935.1
|
Igf2
|
insulin-like growth factor 2 |
chr2_+_84988194 | 7.90 |
ENSMUST00000028466.5
|
Prg3
|
proteoglycan 3 |
chr17_-_23645264 | 7.88 |
ENSMUST00000024696.7
|
Mmp25
|
matrix metallopeptidase 25 |
chr14_+_54476100 | 7.88 |
ENSMUST00000164766.1
ENSMUST00000164697.1 |
Rem2
|
rad and gem related GTP binding protein 2 |
chr11_+_24078022 | 7.87 |
ENSMUST00000000881.6
|
Bcl11a
|
B cell CLL/lymphoma 11A (zinc finger protein) |
chr9_-_44288332 | 7.85 |
ENSMUST00000161408.1
|
Abcg4
|
ATP-binding cassette, sub-family G (WHITE), member 4 |
chr7_+_140093388 | 7.82 |
ENSMUST00000026540.8
|
Prap1
|
proline-rich acidic protein 1 |
chrX_-_36989656 | 7.82 |
ENSMUST00000060474.7
ENSMUST00000053456.4 ENSMUST00000115239.3 |
Sept6
|
septin 6 |
chr17_+_48247759 | 7.81 |
ENSMUST00000048065.5
|
Trem3
|
triggering receptor expressed on myeloid cells 3 |
chr11_+_94990996 | 7.74 |
ENSMUST00000038696.5
|
Ppp1r9b
|
protein phosphatase 1, regulatory subunit 9B |
chr14_-_98169542 | 7.71 |
ENSMUST00000069334.7
ENSMUST00000071533.6 |
Dach1
|
dachshund 1 (Drosophila) |
chr11_+_61956779 | 7.69 |
ENSMUST00000049836.7
|
Specc1
|
sperm antigen with calponin homology and coiled-coil domains 1 |
chr7_+_142471838 | 7.69 |
ENSMUST00000038946.2
|
Lsp1
|
lymphocyte specific 1 |
chr4_+_136172367 | 7.69 |
ENSMUST00000061721.5
|
E2f2
|
E2F transcription factor 2 |
chr2_+_31245801 | 7.66 |
ENSMUST00000000199.7
|
Ncs1
|
neuronal calcium sensor 1 |
chr7_-_133123160 | 7.65 |
ENSMUST00000166439.1
|
Ctbp2
|
C-terminal binding protein 2 |
chr4_-_3938354 | 7.61 |
ENSMUST00000003369.3
|
Plag1
|
pleiomorphic adenoma gene 1 |
chr6_+_115774538 | 7.59 |
ENSMUST00000075995.5
|
Cand2
|
cullin-associated and neddylation-dissociated 2 (putative) |
chr4_-_118620763 | 7.57 |
ENSMUST00000071972.4
|
Wdr65
|
WD repeat domain 65 |
chr11_-_12037391 | 7.57 |
ENSMUST00000093321.5
|
Grb10
|
growth factor receptor bound protein 10 |
chr7_+_29134971 | 7.57 |
ENSMUST00000160194.1
|
Rasgrp4
|
RAS guanyl releasing protein 4 |
chr4_-_44168339 | 7.57 |
ENSMUST00000045793.8
|
Rnf38
|
ring finger protein 38 |
chr15_-_66948419 | 7.56 |
ENSMUST00000167817.1
|
Ndrg1
|
N-myc downstream regulated gene 1 |
chr3_-_152166230 | 7.56 |
ENSMUST00000046614.9
|
Gipc2
|
GIPC PDZ domain containing family, member 2 |
chr10_-_128401218 | 7.55 |
ENSMUST00000042666.5
|
Slc39a5
|
solute carrier family 39 (metal ion transporter), member 5 |
chr19_-_45816007 | 7.54 |
ENSMUST00000079431.3
ENSMUST00000026247.6 ENSMUST00000162528.2 |
Kcnip2
|
Kv channel-interacting protein 2 |
chr3_+_88532314 | 7.52 |
ENSMUST00000172699.1
|
Mex3a
|
mex3 homolog A (C. elegans) |
chrX_+_8271133 | 7.49 |
ENSMUST00000127103.1
ENSMUST00000115591.1 |
Slc38a5
|
solute carrier family 38, member 5 |
chr13_-_37049203 | 7.49 |
ENSMUST00000037491.8
|
F13a1
|
coagulation factor XIII, A1 subunit |
chr10_+_75568648 | 7.46 |
ENSMUST00000134503.1
ENSMUST00000125770.1 ENSMUST00000128886.1 ENSMUST00000151212.1 |
Ggt1
|
gamma-glutamyltransferase 1 |
chr6_+_128362919 | 7.45 |
ENSMUST00000073316.6
|
Foxm1
|
forkhead box M1 |
chr14_-_34201604 | 7.42 |
ENSMUST00000096019.2
|
Gprin2
|
G protein regulated inducer of neurite outgrowth 2 |
chr11_-_96005872 | 7.40 |
ENSMUST00000013559.2
|
Igf2bp1
|
insulin-like growth factor 2 mRNA binding protein 1 |
chr1_+_134182150 | 7.39 |
ENSMUST00000156873.1
|
Chi3l1
|
chitinase 3-like 1 |
chr6_-_136939566 | 7.39 |
ENSMUST00000154440.1
|
Arhgdib
|
Rho, GDP dissociation inhibitor (GDI) beta |
chr6_+_4747306 | 7.38 |
ENSMUST00000175823.1
ENSMUST00000176204.1 ENSMUST00000166678.1 |
Peg10
|
paternally expressed 10 |
chr3_+_108364882 | 7.37 |
ENSMUST00000090563.5
|
Mybphl
|
myosin binding protein H-like |
chr17_+_31208049 | 7.36 |
ENSMUST00000173776.1
|
Ubash3a
|
ubiquitin associated and SH3 domain containing, A |
chr7_-_25072287 | 7.36 |
ENSMUST00000003468.8
|
Grik5
|
glutamate receptor, ionotropic, kainate 5 (gamma 2) |
chr7_-_25005895 | 7.34 |
ENSMUST00000102858.3
ENSMUST00000080882.6 |
Atp1a3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
chrX_+_144688907 | 7.33 |
ENSMUST00000112843.1
|
Zcchc16
|
zinc finger, CCHC domain containing 16 |
chr11_-_102365111 | 7.32 |
ENSMUST00000006749.9
|
Slc4a1
|
solute carrier family 4 (anion exchanger), member 1 |
chr2_-_132029845 | 7.31 |
ENSMUST00000028814.8
|
Rassf2
|
Ras association (RalGDS/AF-6) domain family member 2 |
chr2_+_25242929 | 7.31 |
ENSMUST00000114355.1
ENSMUST00000060818.1 |
Rnf208
|
ring finger protein 208 |
chr1_-_172219715 | 7.30 |
ENSMUST00000170700.1
ENSMUST00000003554.4 |
Casq1
|
calsequestrin 1 |
chr6_+_127887582 | 7.28 |
ENSMUST00000032501.4
|
Tspan11
|
tetraspanin 11 |
chr3_+_108383829 | 7.28 |
ENSMUST00000090561.3
ENSMUST00000102629.1 ENSMUST00000128089.1 |
Psrc1
|
proline/serine-rich coiled-coil 1 |
chr2_+_36216749 | 7.26 |
ENSMUST00000147012.1
ENSMUST00000122948.1 |
Gm13431
|
predicted gene 13431 |
chr16_-_42340595 | 7.25 |
ENSMUST00000102817.4
|
Gap43
|
growth associated protein 43 |
chr17_-_25433775 | 7.24 |
ENSMUST00000159610.1
ENSMUST00000159048.1 ENSMUST00000078496.5 |
Cacna1h
|
calcium channel, voltage-dependent, T type, alpha 1H subunit |
chr2_-_153444441 | 7.22 |
ENSMUST00000109784.1
|
8430427H17Rik
|
RIKEN cDNA 8430427H17 gene |
chr17_-_46629420 | 7.21 |
ENSMUST00000044442.8
|
Ptk7
|
PTK7 protein tyrosine kinase 7 |
chr3_-_100489324 | 7.18 |
ENSMUST00000061455.8
|
Fam46c
|
family with sequence similarity 46, member C |
chr17_+_26941420 | 7.17 |
ENSMUST00000081285.3
ENSMUST00000177932.1 |
Syngap1
|
synaptic Ras GTPase activating protein 1 homolog (rat) |
chr19_+_8591254 | 7.16 |
ENSMUST00000010251.3
ENSMUST00000170817.1 |
Slc22a8
|
solute carrier family 22 (organic anion transporter), member 8 |
chr10_+_75568630 | 7.15 |
ENSMUST00000145928.1
|
Ggt1
|
gamma-glutamyltransferase 1 |
chr12_-_101028983 | 7.14 |
ENSMUST00000068411.3
ENSMUST00000085096.3 |
Ccdc88c
|
coiled-coil domain containing 88C |
chr12_-_32953772 | 7.13 |
ENSMUST00000180391.1
ENSMUST00000181670.1 |
4933406C10Rik
|
RIKEN cDNA 4933406C10 gene |
chr12_-_109068173 | 7.12 |
ENSMUST00000073156.7
|
Begain
|
brain-enriched guanylate kinase-associated |
chr2_-_170427828 | 7.12 |
ENSMUST00000013667.2
ENSMUST00000109152.2 ENSMUST00000068137.4 |
Bcas1
|
breast carcinoma amplified sequence 1 |
chr7_+_143005677 | 7.08 |
ENSMUST00000082008.5
ENSMUST00000105925.1 ENSMUST00000105924.1 |
Tspan32
|
tetraspanin 32 |
chr4_+_130308595 | 7.07 |
ENSMUST00000070532.7
|
Fabp3
|
fatty acid binding protein 3, muscle and heart |
chr5_-_89883321 | 7.05 |
ENSMUST00000163159.1
ENSMUST00000061427.5 |
Adamts3
|
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 3 |
chr2_+_130295148 | 6.99 |
ENSMUST00000110288.2
|
Ebf4
|
early B cell factor 4 |
chr7_-_30821139 | 6.97 |
ENSMUST00000163504.1
|
Ffar2
|
free fatty acid receptor 2 |
chr17_+_47594629 | 6.95 |
ENSMUST00000182846.1
|
Ccnd3
|
cyclin D3 |
chr15_+_73723131 | 6.95 |
ENSMUST00000165541.1
ENSMUST00000167582.1 |
Ptp4a3
|
protein tyrosine phosphatase 4a3 |
chr8_-_80057989 | 6.94 |
ENSMUST00000079038.2
|
Hhip
|
Hedgehog-interacting protein |
chr7_+_143005638 | 6.91 |
ENSMUST00000075172.5
ENSMUST00000105923.1 |
Tspan32
|
tetraspanin 32 |
chr18_-_32559914 | 6.86 |
ENSMUST00000174000.1
ENSMUST00000174459.1 |
Gypc
|
glycophorin C |
chr3_+_14886426 | 6.86 |
ENSMUST00000029078.7
|
Car2
|
carbonic anhydrase 2 |
chr2_+_30834972 | 6.85 |
ENSMUST00000113592.2
|
Prrx2
|
paired related homeobox 2 |
chr5_-_137741601 | 6.85 |
ENSMUST00000119498.1
ENSMUST00000061789.7 |
Nyap1
|
neuronal tyrosine-phosphorylated phosphoinositide 3-kinase adaptor 1 |
chr10_+_43579161 | 6.83 |
ENSMUST00000058714.8
|
Cd24a
|
CD24a antigen |
chrX_-_150813637 | 6.79 |
ENSMUST00000112700.1
|
Maged2
|
melanoma antigen, family D, 2 |
chr11_-_102107822 | 6.78 |
ENSMUST00000177304.1
ENSMUST00000017455.8 |
Pyy
|
peptide YY |
chr10_-_5805412 | 6.77 |
ENSMUST00000019907.7
|
Fbxo5
|
F-box protein 5 |
chr6_+_148047259 | 6.75 |
ENSMUST00000032443.7
|
Far2
|
fatty acyl CoA reductase 2 |
chr15_+_40655020 | 6.74 |
ENSMUST00000053467.4
|
Zfpm2
|
zinc finger protein, multitype 2 |
chr10_+_75568641 | 6.74 |
ENSMUST00000131565.1
|
Ggt1
|
gamma-glutamyltransferase 1 |
chr3_-_89338005 | 6.74 |
ENSMUST00000029674.7
|
Efna4
|
ephrin A4 |
chr8_+_93810832 | 6.74 |
ENSMUST00000034198.8
ENSMUST00000125716.1 |
Gnao1
|
guanine nucleotide binding protein, alpha O |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.6 | 31.8 | GO:0002148 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
10.5 | 31.5 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
9.7 | 77.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
7.6 | 30.5 | GO:1904799 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
7.2 | 21.5 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
6.6 | 19.8 | GO:0030221 | basophil differentiation(GO:0030221) |
6.6 | 19.8 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
6.5 | 25.9 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
6.5 | 19.4 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
4.7 | 37.9 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
4.6 | 37.2 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
4.6 | 13.9 | GO:0031283 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
4.4 | 13.3 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
4.3 | 12.8 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
3.9 | 27.0 | GO:0030421 | defecation(GO:0030421) |
3.8 | 11.5 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
3.7 | 18.3 | GO:0035989 | tendon development(GO:0035989) |
3.6 | 21.3 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
3.5 | 13.9 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
3.4 | 10.1 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
3.3 | 13.4 | GO:0031296 | B cell costimulation(GO:0031296) |
3.3 | 20.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
3.3 | 13.2 | GO:0060032 | notochord regression(GO:0060032) |
3.2 | 12.7 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
3.2 | 3.2 | GO:0035844 | cloaca development(GO:0035844) |
3.0 | 18.2 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
3.0 | 30.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
2.9 | 23.5 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
2.9 | 8.8 | GO:0071918 | urea transmembrane transport(GO:0071918) |
2.9 | 8.8 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
2.9 | 11.4 | GO:1904616 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
2.8 | 8.5 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
2.8 | 5.7 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
2.8 | 16.9 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
2.8 | 8.4 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
2.8 | 11.0 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
2.7 | 24.7 | GO:0010587 | miRNA catabolic process(GO:0010587) |
2.7 | 5.5 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
2.7 | 8.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
2.7 | 26.8 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
2.6 | 20.6 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
2.5 | 7.5 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
2.5 | 7.5 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
2.5 | 14.9 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
2.5 | 9.9 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
2.4 | 14.6 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
2.4 | 7.3 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
2.4 | 9.6 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
2.4 | 7.2 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
2.4 | 7.2 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
2.4 | 7.1 | GO:0035702 | monocyte homeostasis(GO:0035702) |
2.4 | 11.8 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
2.3 | 9.3 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
2.3 | 30.3 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
2.3 | 7.0 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
2.3 | 18.5 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
2.3 | 4.6 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
2.2 | 4.5 | GO:0015675 | nickel cation transport(GO:0015675) |
2.2 | 6.7 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
2.2 | 6.7 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
2.2 | 22.1 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
2.2 | 6.6 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
2.2 | 6.6 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
2.2 | 8.7 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
2.2 | 4.3 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
2.1 | 10.7 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
2.1 | 2.1 | GO:0033128 | negative regulation of histone phosphorylation(GO:0033128) |
2.1 | 17.0 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
2.1 | 21.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
2.1 | 6.3 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
2.1 | 2.1 | GO:0043465 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
2.1 | 12.5 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
2.1 | 6.2 | GO:0060369 | positive regulation of natural killer cell cytokine production(GO:0002729) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
2.0 | 2.0 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
2.0 | 6.1 | GO:0014064 | positive regulation of serotonin secretion(GO:0014064) |
2.0 | 36.4 | GO:0015816 | glycine transport(GO:0015816) |
2.0 | 6.0 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
2.0 | 7.9 | GO:0060912 | cardiac cell fate specification(GO:0060912) |
2.0 | 5.9 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
2.0 | 17.7 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.0 | 9.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.9 | 11.7 | GO:0032796 | uropod organization(GO:0032796) |
1.9 | 5.8 | GO:0002030 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) |
1.9 | 13.6 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
1.9 | 1.9 | GO:1904009 | response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
1.9 | 21.1 | GO:0071435 | potassium ion export(GO:0071435) |
1.9 | 17.3 | GO:0032264 | IMP salvage(GO:0032264) |
1.9 | 9.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.9 | 7.5 | GO:0071226 | cellular response to molecule of fungal origin(GO:0071226) |
1.9 | 7.5 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.9 | 3.7 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
1.9 | 5.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.9 | 7.5 | GO:0015840 | urea transport(GO:0015840) |
1.8 | 9.1 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.8 | 3.6 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
1.8 | 1.8 | GO:1901608 | regulation of vesicle transport along microtubule(GO:1901608) |
1.8 | 5.4 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
1.8 | 5.4 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
1.8 | 10.7 | GO:0006868 | glutamine transport(GO:0006868) |
1.8 | 7.1 | GO:0045575 | basophil activation(GO:0045575) |
1.8 | 26.6 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
1.8 | 8.8 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
1.8 | 5.3 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) cell proliferation involved in embryonic placenta development(GO:0060722) |
1.7 | 8.6 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
1.7 | 6.9 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
1.7 | 5.1 | GO:0072278 | metanephric comma-shaped body morphogenesis(GO:0072278) |
1.7 | 6.8 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
1.7 | 47.3 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
1.7 | 5.0 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
1.7 | 10.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.7 | 5.0 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
1.6 | 9.9 | GO:0060022 | hard palate development(GO:0060022) |
1.6 | 4.9 | GO:0071481 | cellular response to X-ray(GO:0071481) |
1.6 | 8.2 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
1.6 | 3.2 | GO:0070560 | protein secretion by platelet(GO:0070560) |
1.6 | 6.5 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
1.6 | 3.2 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
1.6 | 1.6 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
1.6 | 4.8 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
1.6 | 1.6 | GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity(GO:2000277) |
1.5 | 6.2 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
1.5 | 10.8 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
1.5 | 7.7 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
1.5 | 7.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.5 | 1.5 | GO:0033058 | directional locomotion(GO:0033058) |
1.5 | 1.5 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
1.5 | 6.0 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.5 | 4.5 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
1.5 | 7.4 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.5 | 4.4 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
1.5 | 3.0 | GO:0090172 | microtubule cytoskeleton organization involved in homologous chromosome segregation(GO:0090172) |
1.5 | 4.4 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) |
1.5 | 5.9 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
1.5 | 4.4 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
1.5 | 1.5 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
1.5 | 8.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.4 | 4.3 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) formin-nucleated actin cable assembly(GO:0070649) |
1.4 | 4.3 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
1.4 | 4.3 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
1.4 | 2.9 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
1.4 | 19.7 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
1.4 | 2.8 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.4 | 1.4 | GO:0046832 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
1.4 | 5.6 | GO:1902896 | terminal web assembly(GO:1902896) |
1.4 | 1.4 | GO:0035372 | protein localization to microtubule(GO:0035372) |
1.4 | 4.1 | GO:0071313 | cellular response to caffeine(GO:0071313) |
1.4 | 11.0 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.4 | 5.5 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
1.4 | 19.0 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
1.4 | 4.1 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
1.4 | 5.4 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
1.3 | 4.0 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
1.3 | 5.4 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
1.3 | 6.7 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
1.3 | 5.3 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
1.3 | 8.0 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
1.3 | 6.6 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
1.3 | 1.3 | GO:1903438 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
1.3 | 5.3 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
1.3 | 7.9 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
1.3 | 7.9 | GO:0031133 | regulation of axon diameter(GO:0031133) |
1.3 | 11.7 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.3 | 14.3 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
1.3 | 1.3 | GO:0003383 | apical constriction(GO:0003383) |
1.3 | 3.9 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
1.3 | 2.6 | GO:0051885 | positive regulation of anagen(GO:0051885) |
1.3 | 2.6 | GO:2000978 | negative regulation of forebrain neuron differentiation(GO:2000978) |
1.3 | 5.2 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.3 | 5.2 | GO:1902340 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
1.3 | 10.2 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
1.3 | 3.8 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
1.3 | 5.1 | GO:0032053 | ciliary basal body organization(GO:0032053) |
1.3 | 3.8 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
1.3 | 3.8 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
1.3 | 5.0 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.3 | 2.5 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
1.2 | 2.5 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
1.2 | 5.0 | GO:0042125 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
1.2 | 4.9 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) |
1.2 | 13.6 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
1.2 | 4.9 | GO:1903575 | cornified envelope assembly(GO:1903575) |
1.2 | 15.9 | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
1.2 | 4.9 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
1.2 | 9.7 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
1.2 | 6.0 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
1.2 | 2.4 | GO:1990523 | bone regeneration(GO:1990523) |
1.2 | 4.8 | GO:0007494 | midgut development(GO:0007494) |
1.2 | 1.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.2 | 4.8 | GO:0046898 | response to cycloheximide(GO:0046898) |
1.2 | 2.4 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
1.2 | 3.5 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
1.2 | 1.2 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
1.2 | 1.2 | GO:0048389 | intermediate mesoderm development(GO:0048389) pattern specification involved in mesonephros development(GO:0061227) anterior/posterior pattern specification involved in kidney development(GO:0072098) |
1.2 | 1.2 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
1.2 | 13.8 | GO:0002679 | respiratory burst involved in inflammatory response(GO:0002536) respiratory burst involved in defense response(GO:0002679) |
1.2 | 5.8 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
1.1 | 5.7 | GO:1990034 | calcium ion export from cell(GO:1990034) |
1.1 | 6.9 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
1.1 | 22.8 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
1.1 | 2.3 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
1.1 | 3.3 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
1.1 | 4.4 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
1.1 | 3.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
1.1 | 6.6 | GO:0007144 | female meiosis I(GO:0007144) |
1.1 | 4.4 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.1 | 4.4 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
1.1 | 4.4 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
1.1 | 4.4 | GO:0032218 | riboflavin transport(GO:0032218) |
1.1 | 4.4 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
1.1 | 4.4 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
1.1 | 5.4 | GO:0071105 | response to interleukin-11(GO:0071105) |
1.1 | 3.3 | GO:0061054 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
1.1 | 4.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.1 | 3.2 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) |
1.1 | 11.9 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.1 | 3.2 | GO:0051466 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
1.1 | 15.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
1.1 | 2.1 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
1.1 | 3.2 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
1.1 | 3.2 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
1.0 | 2.1 | GO:1905203 | regulation of connective tissue replacement(GO:1905203) |
1.0 | 4.2 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
1.0 | 6.2 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
1.0 | 7.2 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.0 | 3.1 | GO:0010920 | negative regulation of inositol phosphate biosynthetic process(GO:0010920) |
1.0 | 4.1 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
1.0 | 3.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.0 | 1.0 | GO:0032762 | mast cell cytokine production(GO:0032762) |
1.0 | 6.1 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
1.0 | 1.0 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
1.0 | 4.0 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
1.0 | 12.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
1.0 | 2.0 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.0 | 8.0 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
1.0 | 3.0 | GO:0070843 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
1.0 | 8.0 | GO:0015074 | DNA integration(GO:0015074) |
1.0 | 3.0 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
1.0 | 3.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
1.0 | 5.0 | GO:0035993 | subthalamic nucleus development(GO:0021763) deltoid tuberosity development(GO:0035993) superior vena cava morphogenesis(GO:0060578) |
1.0 | 1.0 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
1.0 | 14.7 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.0 | 6.8 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
1.0 | 1.9 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
1.0 | 8.7 | GO:0002432 | granuloma formation(GO:0002432) |
1.0 | 3.8 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
1.0 | 1.0 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
1.0 | 2.9 | GO:0099547 | regulation of translation at synapse, modulating synaptic transmission(GO:0099547) regulation of translation at postsynapse, modulating synaptic transmission(GO:0099578) positive regulation of intracellular transport of viral material(GO:1901254) |
0.9 | 6.6 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.9 | 6.6 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.9 | 7.6 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.9 | 2.8 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.9 | 2.8 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.9 | 0.9 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.9 | 1.9 | GO:0060166 | olfactory pit development(GO:0060166) |
0.9 | 7.4 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
0.9 | 4.6 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.9 | 5.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.9 | 5.5 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
0.9 | 1.8 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.9 | 11.9 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.9 | 9.1 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.9 | 2.7 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.9 | 0.9 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.9 | 1.8 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.9 | 0.9 | GO:0071415 | cellular response to purine-containing compound(GO:0071415) |
0.9 | 2.7 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.9 | 2.7 | GO:1904978 | regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
0.9 | 6.2 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.9 | 4.5 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.9 | 44.5 | GO:0051693 | actin filament capping(GO:0051693) |
0.9 | 7.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.9 | 9.8 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.9 | 0.9 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.9 | 11.5 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.9 | 0.9 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.9 | 1.8 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.9 | 1.8 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.9 | 7.0 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.9 | 2.6 | GO:0051794 | regulation of catagen(GO:0051794) |
0.9 | 15.8 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.9 | 0.9 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.9 | 16.7 | GO:0007614 | short-term memory(GO:0007614) |
0.9 | 4.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.9 | 0.9 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
0.9 | 6.9 | GO:0034650 | aldosterone biosynthetic process(GO:0032342) cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
0.9 | 1.7 | GO:0072049 | comma-shaped body morphogenesis(GO:0072049) |
0.9 | 2.6 | GO:1904395 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.9 | 2.6 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.9 | 3.4 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.8 | 1.7 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.8 | 3.4 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.8 | 33.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.8 | 6.8 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.8 | 3.4 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.8 | 22.8 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.8 | 3.4 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.8 | 4.2 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.8 | 5.0 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.8 | 0.8 | GO:1902462 | mesenchymal stem cell proliferation(GO:0097168) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.8 | 30.9 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.8 | 1.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.8 | 18.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.8 | 4.2 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.8 | 0.8 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.8 | 3.3 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.8 | 1.6 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.8 | 9.8 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.8 | 3.3 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.8 | 1.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.8 | 8.1 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.8 | 4.0 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.8 | 2.4 | GO:0055130 | D-serine catabolic process(GO:0036088) D-alanine family amino acid metabolic process(GO:0046144) D-alanine metabolic process(GO:0046436) D-alanine catabolic process(GO:0055130) |
0.8 | 0.8 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.8 | 6.4 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
0.8 | 3.2 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.8 | 1.6 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
0.8 | 7.1 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.8 | 3.9 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.8 | 14.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.8 | 2.3 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.8 | 6.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.8 | 3.9 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.8 | 2.3 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.8 | 3.8 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.8 | 5.3 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.8 | 5.3 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.8 | 15.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.8 | 3.8 | GO:0060613 | fat pad development(GO:0060613) |
0.8 | 3.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.8 | 2.3 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.8 | 4.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.7 | 9.0 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.7 | 4.5 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.7 | 0.7 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.7 | 5.8 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.7 | 5.8 | GO:0061718 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.7 | 2.8 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.7 | 3.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.7 | 6.3 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.7 | 2.1 | GO:0072720 | response to dithiothreitol(GO:0072720) |
0.7 | 19.6 | GO:0048821 | erythrocyte development(GO:0048821) |
0.7 | 2.8 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.7 | 0.7 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.7 | 8.3 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.7 | 2.8 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.7 | 5.6 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.7 | 2.1 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.7 | 4.8 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.7 | 3.4 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.7 | 6.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.7 | 3.4 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.7 | 2.7 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.7 | 4.1 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.7 | 2.7 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) |
0.7 | 5.4 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.7 | 2.7 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.7 | 0.7 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.7 | 10.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.7 | 4.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.7 | 3.3 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.7 | 3.3 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.7 | 4.0 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.7 | 2.6 | GO:0015867 | ATP transport(GO:0015867) |
0.6 | 1.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.6 | 2.6 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.6 | 3.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.6 | 1.9 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.6 | 1.9 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.6 | 9.0 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.6 | 5.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.6 | 5.1 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.6 | 2.5 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.6 | 3.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.6 | 1.3 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.6 | 1.9 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.6 | 5.6 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.6 | 0.6 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.6 | 5.0 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.6 | 1.9 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.6 | 3.7 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.6 | 2.5 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.6 | 1.9 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.6 | 2.5 | GO:0072553 | terminal button organization(GO:0072553) |
0.6 | 1.2 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.6 | 6.8 | GO:0006968 | cellular defense response(GO:0006968) |
0.6 | 5.6 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.6 | 2.5 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.6 | 4.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.6 | 3.0 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.6 | 18.8 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.6 | 2.4 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.6 | 1.2 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.6 | 0.6 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.6 | 0.6 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.6 | 1.8 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.6 | 3.6 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.6 | 3.6 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.6 | 1.2 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.6 | 8.8 | GO:0030220 | platelet formation(GO:0030220) |
0.6 | 2.3 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.6 | 14.1 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.6 | 1.2 | GO:0036292 | DNA rewinding(GO:0036292) |
0.6 | 4.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.6 | 1.2 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
0.6 | 6.4 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.6 | 1.2 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.6 | 2.9 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.6 | 1.7 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.6 | 1.1 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
0.6 | 16.6 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.6 | 3.4 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.6 | 1.1 | GO:0099553 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.6 | 0.6 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.6 | 2.8 | GO:0030432 | peristalsis(GO:0030432) |
0.6 | 6.2 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
0.6 | 2.2 | GO:0061623 | glycolytic process from galactose(GO:0061623) |
0.6 | 7.8 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.6 | 7.8 | GO:0051451 | myoblast migration(GO:0051451) |
0.6 | 1.1 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.6 | 3.9 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.6 | 1.1 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
0.6 | 2.2 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.5 | 29.7 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.5 | 2.2 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.5 | 2.2 | GO:0030576 | Cajal body organization(GO:0030576) |
0.5 | 1.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.5 | 4.3 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.5 | 1.6 | GO:0042376 | menaquinone metabolic process(GO:0009233) phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.5 | 2.7 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.5 | 1.6 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.5 | 5.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.5 | 2.7 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.5 | 20.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.5 | 3.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.5 | 2.1 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.5 | 2.1 | GO:0010286 | heat acclimation(GO:0010286) |
0.5 | 4.2 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.5 | 2.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.5 | 8.5 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.5 | 2.1 | GO:0061743 | motor learning(GO:0061743) |
0.5 | 1.1 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.5 | 1.1 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.5 | 2.1 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.5 | 2.6 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.5 | 3.1 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.5 | 2.6 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.5 | 1.5 | GO:0071846 | actin filament debranching(GO:0071846) |
0.5 | 4.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.5 | 3.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.5 | 3.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.5 | 2.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.5 | 3.6 | GO:1904923 | regulation of mitophagy in response to mitochondrial depolarization(GO:1904923) |
0.5 | 1.5 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.5 | 2.0 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.5 | 1.5 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.5 | 2.0 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.5 | 1.5 | GO:2000570 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
0.5 | 8.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.5 | 1.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.5 | 1.0 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.5 | 2.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.5 | 1.0 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.5 | 2.9 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.5 | 4.4 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.5 | 5.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.5 | 2.9 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.5 | 1.0 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.5 | 1.5 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.5 | 0.5 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.5 | 1.9 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.5 | 0.5 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.5 | 2.4 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.5 | 3.4 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.5 | 1.4 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.5 | 3.4 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.5 | 7.7 | GO:0032095 | regulation of response to food(GO:0032095) |
0.5 | 1.4 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.5 | 2.4 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.5 | 1.4 | GO:0015808 | L-alanine transport(GO:0015808) |
0.5 | 1.9 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.5 | 1.0 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.5 | 2.9 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.5 | 1.0 | GO:1904749 | protein localization to nucleolus(GO:1902570) regulation of protein localization to nucleolus(GO:1904749) |
0.5 | 1.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.5 | 3.8 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.5 | 2.4 | GO:1905171 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
0.5 | 1.4 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.5 | 10.4 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.5 | 1.9 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
0.5 | 13.5 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.5 | 0.9 | GO:0060775 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
0.5 | 0.9 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.5 | 11.2 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.5 | 1.4 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.5 | 0.5 | GO:0099625 | ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.5 | 1.8 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.5 | 0.5 | GO:0001781 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
0.5 | 3.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.5 | 0.9 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.5 | 2.7 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.5 | 14.5 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.5 | 0.5 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
0.5 | 1.4 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) positive regulation of neurotransmitter transport(GO:0051590) |
0.5 | 1.8 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.5 | 5.0 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.5 | 0.5 | GO:0061055 | myotome development(GO:0061055) |
0.5 | 0.5 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.5 | 0.9 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
0.4 | 3.6 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.4 | 3.1 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.4 | 0.9 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
0.4 | 1.8 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.4 | 1.3 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |